Department of Obstetrics & Gynecology

Medicine & Life Sciences

1. Ovarian Neoplasms 100%
2. Uterine Cervical Neoplasms 87%
3. Hysterectomy 77%
4. Neoplasms 67%
5. Pelvic Organ Prolapse 54%
6. Carcinoma 53%
7. Gynecologic Surgical Procedures 52%
8. Robotics 49%
9. Endometrial Neoplasms 43%
10. Lymph Node Excision 36%
11. Therapeutics 31%
12. Laparoscopy 31%
13. Trachelectomy 30%
14. Cervix Uteri 29%
15. Ovarian Epithelial Carcinoma 27%
16. Prolapse 26%
17. Systematic Reviews 26%
18. Recurrence 26%
19. Pregnancy 25%
20. Drug Therapy 22%
21. Vulva 21%
22. Neoplasm Metastasis 20%
23. Vagina 20%
24. Pelvic Exenteration 20%
25. Skin 18%
26. Lymph Nodes 18%
27. Suburethral Slings 18%
28. Survival 17%
29. Sentinel Lymph Node 17%
30. Fertility 17%
31. Cholesterol 17%
32. Docetaxel 16%
33. Minimally Invasive Surgical Procedures 16%
34. Length of Stay 16%
35. Surgeons 16%
36. Pelvic Floor 15%
37. Ovary 15%
38. Endometriosis 14%
39. Radiotherapy 14%
40. Zebrafish 14%
41. Growth 14%
42. Adenocarcinoma 14%
43. Conization 14%
44. Endothelial Cells 13%
45. Lipids 12%
46. Operative Time 12%
47. Squamous Cell Carcinoma 12%
48. Carboplatin 12%
49. Oncologists 12%
50. Granulosa Cell Tumor 11%
51. Laparotomy 11%
52. Breast Neoplasms 11%
53. Atherosclerosis 11%
54. Relaxin 11%
55. Stress Urinary Incontinence 11%
56. Topotecan 11%
57. Paclitaxel 11%
58. Gynecology 11%
59. Dyspareunia 11%
60. Body Mass Index 11%
61. Macrophages 11%
62. In Vitro Techniques 11%
63. Nanoparticles 11%
64. Vaginal Hysterectomy 10%
65. Randomized Controlled Trials 10%
66. Medicine 10%
67. Fecal Incontinence 10%
68. Pelvis 10%
69. Small Interfering RNA 10%
70. Carrier Proteins 10%
71. Meta-Analysis 10%
72. Blood Vessels 10%
73. Biopsy 9%
74. Cell-Free Nucleic Acids 9%
75. Vulvar Neoplasms 9%
76. Platinum 9%
77. Homocysteine 9%
78. Peritoneum 9%
79. Incidence 9%
80. Pharmaceutical Preparations 9%
81. Morbidity 9%
82. Thymidine Kinase 9%
83. Leiomyoma 8%
84. Quality of Life 8%
85. Focal Adhesion Protein-Tyrosine Kinases 8%
86. Liposomes 8%
87. Polypropylenes 8%
88. Salpingo-oophorectomy 8%
89. Microvessels 8%
90. taxane 8%
91. Vascular Endothelial Growth Factor A 8%
92. Groin 8%
93. Genes 8%
94. Pelvic Floor Disorders 8%
95. Uterine Prolapse 8%
96. Healthcare Disparities 8%
97. Uterus 8%
98. Urinary Diversion 8%
99. Confidence Intervals 8%
100. Safety 7%